Sarda Proteins Ltd. (SRDAPRT.BO)
INR 113.2
(0.0%)
INR 113.2
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -657 Thousand | -1.41 Million | 1.89 Million | 315.5 Thousand | 316.78 Thousand | -5.16 Million |
| Net Income | 194 Thousand | -330.29 Thousand | 3.07 Million | -202.78 Thousand | 329.17 Thousand | -1.23 Million |
| Depreciation & Amortization | - | - | 4690.00 | 4758.00 | 33.12 Thousand | 89.76 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -858 Thousand | -1.54 Million | -1.66 Million | -206.3 Thousand | -1.15 Million | -4.08 Million |
| Other non-cash items | 865 Thousand | 2 Million | 2.14 Million | 958.43 Thousand | 2.33 Million | 4.33 Million |
| Investing Cash Flow | - | - | 24 Thousand | - | 84 Thousand | 411.64 Thousand |
| Investments in PPE | -1.3 Million | - | - | - | - | - |
| Acquisitions | - | - | 24 Thousand | - | 84 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.3 Million | - | - | - | - | 411.64 Thousand |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | -73.45 Thousand | 73.45 Thousand |
| Debt repayment | - | - | - | - | -73.45 Thousand | -73.45 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 146.9 Thousand |
| Accounts receivables | -967 Thousand | -1.39 Million | -1.78 Million | -247.77 Thousand | -465.97 Thousand | -8.24 Million |
| Accounts payables | 109 Thousand | -151.16 Thousand | 121.43 Thousand | 18.69 Thousand | -690.43 Thousand | -135.84 Thousand |
| Inventory | - | - | - | - | - | 4.29 Million |
| Other working capital | - | - | - | 22.77 Thousand | - | - |
| Cash at beginning of period | 1.84 Million | 3.25 Million | 1.33 Million | 1.02 Million | 496.28 Thousand | 5.37 Million |
| Cash at end of period | 1.18 Million | 1.84 Million | 3.25 Million | 1.33 Million | 1.02 Million | 496.28 Thousand |
| Capital Expenditure | -1.3 Million | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 200 Thousand | 0.10 |
| Net cash flow / Change in cash | -656.67 Thousand | -1.41 Million | 1.91 Million | 315.5 Thousand | 527.33 Thousand | -4.87 Million |
| Free Cash Flow | -1.95 Million | -1.41 Million | 1.89 Million | 315.5 Thousand | 316.78 Thousand | -5.16 Million |
| Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY | 2018 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 194 Thousand | -330.29 Thousand | 3.07 Million | -202.78 Thousand | 329.17 Thousand | -1.23 Million |
| Depreciation & Amortization | - | - | 4690.00 | 4758.00 | 33.12 Thousand | 89.76 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -858 Thousand | -1.54 Million | -1.66 Million | -206.3 Thousand | -1.15 Million | -4.08 Million |
| Other non-cash items | 865 Thousand | 2 Million | 2.14 Million | 958.43 Thousand | 2.33 Million | 4.33 Million |
| Investing Cash Flow | - | - | 24 Thousand | - | 84 Thousand | 411.64 Thousand |
| Investments in PPE | -1.3 Million | - | - | - | - | - |
| Acquisitions | - | - | 24 Thousand | - | 84 Thousand | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 1.3 Million | - | - | - | - | 411.64 Thousand |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | - | - | -73.45 Thousand | 73.45 Thousand |
| Debt repayment | - | - | - | - | -73.45 Thousand | -73.45 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | 146.9 Thousand |
| Accounts receivables | -967 Thousand | -1.39 Million | -1.78 Million | -247.77 Thousand | -465.97 Thousand | -8.24 Million |
| Accounts payables | 109 Thousand | -151.16 Thousand | 121.43 Thousand | 18.69 Thousand | -690.43 Thousand | -135.84 Thousand |
| Inventory | - | - | - | - | - | 4.29 Million |
| Other working capital | - | - | - | 22.77 Thousand | - | - |
| Cash at beginning of period | 1.84 Million | 3.25 Million | 1.33 Million | 1.02 Million | 496.28 Thousand | 5.37 Million |
| Cash at end of period | 1.18 Million | 1.84 Million | 3.25 Million | 1.33 Million | 1.02 Million | 496.28 Thousand |
| Capital Expenditure | -1.3 Million | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | 200 Thousand | 0.10 |
| Net cash flow / Change in cash | -656.67 Thousand | -1.41 Million | 1.91 Million | 315.5 Thousand | 527.33 Thousand | -4.87 Million |
| Free Cash Flow | -1.95 Million | -1.41 Million | 1.89 Million | 315.5 Thousand | 316.78 Thousand | -5.16 Million |
GEFR
IVRO
600711
2658
MLGF
2931